Suppr超能文献

线粒体在 mTOR 调控的长寿中的作用。

The role of mitochondria in mTOR-regulated longevity.

机构信息

No.3 People's Hospital, School of Medicine, Shanghai Jiao Tong University, 280 Mohe Road, Shanghai, 201900, China.

出版信息

Biol Rev Camb Philos Soc. 2015 Feb;90(1):167-81. doi: 10.1111/brv.12103. Epub 2014 Mar 28.

Abstract

Several unbiased genome-wide RNA interference (RNAi) screens have pointed to mitochondrial metabolism as the major factor for lifespan regulation. However, conflicting data remain to be clarified concerning the mitochondrial free radical theory of aging (MFRTA). Recently, mTOR (mechanistic target of rapamycin) has been proposed to be the central regulator of aging although how mTOR modulates lifespan is poorly understood. Interestingly, mTOR has been shown to regulate many aspects of mitochondrial function, such as mitochondrial biogenesis, apoptosis, mitophagy and mitochondrial hormesis (mitohormesis) including the retrograde response and mitochondrial unfolded protein response (mito-UPR). Here we discuss the data linking mitochondrial metabolism to mTOR regulation of lifespan, suggesting that hormetic effects may be key to explaining some controversial results regarding the MFRTA. We also discuss the possibility that dysfunction of mitochondrial adaptive responses rather than free radicals per se contributes to the aging process.

摘要

几项无偏倚的全基因组 RNA 干扰 (RNAi) 筛选表明,线粒体代谢是调节寿命的主要因素。然而,关于衰老的线粒体自由基理论 (MFRTA),仍存在一些相互矛盾的数据需要澄清。最近,mTOR(雷帕霉素的靶蛋白)被提议为衰老的中央调节因子,尽管 mTOR 如何调节寿命还知之甚少。有趣的是,mTOR 已被证明可以调节线粒体功能的许多方面,如线粒体生物发生、细胞凋亡、线粒体自噬和线粒体应激(mitohormesis),包括逆行反应和线粒体未折叠蛋白反应(mito-UPR)。在这里,我们讨论了将线粒体代谢与 mTOR 调节寿命联系起来的研究数据,表明应激效应可能是解释一些关于 MFRTA 的有争议结果的关键。我们还讨论了线粒体适应性反应功能障碍而不是自由基本身导致衰老过程的可能性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验